Overview

TIPS vs Endoscopic Therapy for Variceal Rebleeding in Cirrhotic Patients With Portal Vein Thrombosis

Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
portal vein thrombosis may be a negative prognostic marker of variceal bleeding in liver cirrhosis. Compared with conventional endoscopic and pharmacological therapy, transjugular intrahepatic portosystemic shunt may further improve the outcomes of portal vein thrombosis in liver cirrhosis with variceal bleeding.
Phase:
N/A
Details
Lead Sponsor:
Air Force Military Medical University, China
Fourth Military Medical University
Collaborators:
First Affiliated Hospital of Xinjiang Medical University
Shandong Provincial Hospital
Southern Medical University, China
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
The First Affiliated Hospital of Nanchang University
Third Affiliated Hospital, Sun Yat-Sen University
Treatments:
Adrenergic beta-Antagonists
Propranolol
Warfarin